CC(C)c1ccc(NC(=O)C(c2ccccc2)N(Cc2ccco2)C(=O)CC2NC(=O)NC2=O)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?